Category: Aptar

The Yokneam-based company has developed an intranasal drug delivery system to precisely target areas of the nasal cavity to enable systemic, local or even direct delivery to the brain. American drug delivery company Aptar Pharma announced the acquisition of the device technology assets of an Israeli company SipNose nasal delivery…